PCORI approves $42 million in funding for comparative studies on healthcare approaches

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Patient-Centered Outcomes Research Institute Board of Governors has green-lighted nearly $42 million to fund 19 new studies comparing which healthcare approaches work best.

Thirteen of the projects will support research on which care options work best in treating a range of conditions and problems that impose high burdens on patients, caregivers, and the healthcare system. These include:

  • A $6 million study to compare the effectiveness of two types of palliative care, hospital-based versus home-based, in reducing patients’ pain, anxiety and depression.

  • A $2.7 million study to determine the effect of accupressure on relieving treatment-related symptoms in children with cancer.

  • A $2.3 million project to determine whether established treatment or a newer drug is more effective against treatment-resistant cases of Kawasaki disease, which can cause heart problems in children.

Another six projects will study ways to improve methods for conducting patient-centered outcomes research. Among them are projects on assessing the quality of communications between healthcare providers and patients, preserving patient privacy when data sets including medical information are linked, and measuring patients’ preferences.

YOU MAY BE INTERESTED IN

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login